Research and Development

A man left brain dead after a clinical trial in France has died in hospital and five remain in a …

Six patients have been left in a critical condition following a serious accident in a clinical trial at a French …

Sanofi Pasteur has become the latest pharma company to add funding to The Human Vaccines Project – a non-profit public-private …

AbbVie has appointed Esteban Plata as vice president of Western Europe and Canada.He replaces Pascale Richetta who is retiring from …

A new study has revealed a belief among pharma industry executives that greater involvement of patients and the public could …

Takeda is funding the research charity Myeloma UK to run a Phase II study of its multiple myeloma treatment Ninlaro, …

Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …

Having emerged from its mega-merger deal with Shire, Baxalta is back on its drug development day job – and has …

Israeli biopharma company BioLineRx has announced a collaboration with MSD on a Phase II study investigating its lead oncology candidate, …

Celgene and Amgen are among the large biopharma companies that have agreed to join the National Immunotherapy Coalition (NIC), a …

A senate panel has approved president Obama’s nominee Dr Robert Califf to lead the FDA by a clear majority, although …

Takeda is teaming up with Canadian biotech enGene to develop novel therapies for specialty gastrointestinal (GI) diseases, using enGene’s ‘gene …

AstraZeneca’s biologics R&D arm MedImmune and the University of California, San Francisco (UCSF) have announced a new research collaboration focused …

US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …

AstraZeneca and its biologics arm MedImmune are launching new agreements with partner companies, to develop new targets for cancer, and …